Table 2 Experimental characteristics of preclinical immune checkpoint blockade treatments
Experimental design characteristics | Median (Range) |
|---|---|
Mice per treatment group | 10 (4–45) |
Studies per treatment group | 3 (1 – 79) |
Cell lines per treatment group | 3 (1–48) |